Influence of multifocal intraocular lens on glaucoma diagnostic tests

Influence of multifocal intraocular lens on glaucoma diagnostic tests - multifocal intraocular lens and glaucoma tests

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40755

Enrollment

Registered

2014-07-31

Start date

2014-10-25

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

implants Multifocal intraocular lens

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients implanted with a MFIOL aged between 18 an 70, who are able and willing to participate in this study. - Postoperative period of at least 3 months. - One eye will be randomly chosen and tested with the exception of the FDT. This device can only perform the test if both eyes are analysed.

Exclusion criteria

Exclusion criteria: - Best correct visual acuity (BCVA) of ±5D or a cylinder of >±2.5D. - Intra ocular pressure (IOP) of >22mmHg. - Optic nerve abnormalities indicating glaucoma - Repeatable VF-defects detected with perimetry (not explained by the MFIOL in patients) - History or current serious eye disease, trauma or surgery.

Design outcomes

Primary

Measure	Time frame
FDT: number of abnormal test locations; OCT: thickness of the retinal nerve fibre layer (RNFL) and the retinal ganglion cell layer (RGCL); GDx: the nerve fibre index	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results